Immunopathogenesis of myositis

被引:0
作者
Hohlfeld, R [1 ]
机构
[1] MAX PLANCK INST, ABT NEUROIMMUNOL, MARTINSRIED, GERMANY
关键词
dermatomyositis; polymyositis; inclusion body myositis; pathogenesis; CYTOTOXIC T-CELLS; INFLAMMATORY MYOPATHIES; LYMPHOCYTES-T; HUMAN MYOBLASTS; GAMMA; EXPRESSION; MYOTUBES; MUSCLE; RECEPTOR;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
These inflammatory muscular disorders include dermatomyositis (DM), polymyositis (PM) and inclusion body myositis (IBM). One of the characteristic histological features of DM is ''perifascicular atrophy''. Immunohistochemical analyses in DM show deposition of complement proteins in capillaries. The patients probably produce pathological antibodies that react with components of the muscle endothelial cells, thus causing secondary deposition of complement. In contrast, PM is marked by a cellular injury mechanism. The characteristic histological feature is endomysial T cell infiltration, consisting predominantly of CD8-positive T lymphocytes. These cytotoxic T cells surround and invade individual muscle fibres. This culminates in destruction of the muscle fibre. The attacked muscle fibres express class I (HLA-A, B, C) histocompatibility antigens. It is likely that the CD-8 positive T lymphocytes recognise muscular autoantigens as HLA-bound peptides. The active autoantigens are still unknown. In IBM - though not in PM - electron-microscopy reveals intranuclear and intracytoplasmic filaments that resemble myxoviruses. Hence, although it is possible that IBM is based on a virus infection, this has not been proved. Other investigations have shown interesting immunohistochemical similarities between IBM and Alzheimer's disease.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [11] Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets
    Haq, Syed A.
    Tournadre, Anne
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2015, 18 (08) : 818 - 825
  • [12] FAST-TWITCH SARCOMERIC AND GLYCOLYTIC ENZYME PROTEIN LOSS IN INCLUSION BODY MYOSITIS
    Parker, Kenneth C.
    Kong, Sek Won
    Walsh, Ronan J.
    Salajegheh, Mohammad
    Moghadaszadeh, Behzad
    Amato, Anthony A.
    Nazareno, Remedios
    Lin, Yin Yin
    Krastins, Bryan
    Sarracino, David A.
    Beggs, Alan H.
    Pinkus, Jack L.
    Greenberg, Steven A.
    MUSCLE & NERVE, 2009, 39 (06) : 739 - 753
  • [13] Pathogenesis of muscle weakness in inflammatory myositis
    Dunga, Sai Kumar
    Sundaram, T. G.
    Kavadichanda, Chengappa G.
    INDIAN JOURNAL OF RHEUMATOLOGY, 2020, 15 (06) : 99 - 111
  • [14] Standard treatment for myositis and muscular dystrophies
    Schmidt, J.
    Vorgerd, M.
    NERVENARZT, 2011, 82 (06): : 723 - +
  • [15] PERMISSIVE ENVIRONMENT FOR B-CELL MATURATION IN MYOSITIS MUSCLE IN THE ABSENCE OF B-CELL FOLLICLES
    Salajegheh, Mohammad
    Pinkus, Jack L.
    Amato, Anthony A.
    Morehouse, Chris
    Jallal, Bahija
    Yao, Yihong
    Greenberg, Steven A.
    MUSCLE & NERVE, 2010, 42 (04) : 576 - 583
  • [16] Juvenile Dermatomyositis: Immunopathogenesis, Role of Myositis-Specific Autoantibodies, and Review of Rituximab Use
    Chiu, Yvonne E.
    Co, Dominic O.
    PEDIATRIC DERMATOLOGY, 2011, 28 (04) : 357 - 367
  • [17] Diagnostic delay of myositis: an integrated systematic review
    Namsrai, Tergel
    Parkinson, Anne
    Chalmers, Anita
    Lowe, Christine
    Cook, Matthew
    Phillips, Christine
    Desborough, Jane
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [18] Autoimmune myositis-Mechanism and therapy development
    Uruha, Akinori
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2022, 10 (06): : 279 - 288
  • [19] Therapy of myositis
    Keck, A. D.
    Walker, U. A.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (03): : 227 - +
  • [20] Autoimmune myositis
    Walker, UA
    Ketelsen, UP
    Peter, HH
    ALLERGOLOGIE, 2000, 23 (04) : 171 - 181